Effect of pimozide on positive and negative symptoms in schizophrenic patients: Are negative symptoms state dependent?

Neuropsychobiology

Volumn 18, Issue 3, 1987, Pages 113-117

  Van Kammen, Daniel P ^a   Hommer, Daniel W ^a,b   Malas, Kenneth L ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Negative schizophrenic symptoms; Pimozide; Schizophrenia

Indexed keywords

PIMOZIDE;

ADULT; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; SCHIZOPHRENIA;

ADOLESCENT; ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; MIDDLE AGE; PIMOZIDE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0023613496     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000118403     Document Type: Article

References (22)

1. Andreasen, N.: Negative symptoms in schizophrenia. Archs gen. Psychiat. 39: 784-788 (1982).
2. Angrist, B., Rotrosen, J., Gershon, S.: Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology 72: 17-19 (1980).
3. Berenbaum, S., Abrams, R., Rosenberg, S., Taylor, M.: The nature of emotional blunting: a factor-analytic study. Psychiat. Res. 20: 57-67 (1987).
4. Bunncy, W. Jr., Hamburg, D.: Methods for reliable observation of behavior. Archs gen. Psychiat. 9: 280-294 (1963).
5. Crow, T.: Molecular pathology of schizophrenia: more than one disease process. Br. mcd. J. 280: 66-68 (1980).
6. Friedhoff, A.: A dopamine-dependent restitutive system for the maintenance of mental normalcy. Ann. N. Y. Acad. Sci. 463: (1986).
7. Goldberg, S., Cole, J.: National Institute of Mental Health Psy-chopharmacology Service Center Collaborative Study Group: phenothiazinc treatment in acute schizophrenia. Arehs gen. Psychiat. 10: 246-261 (1964).
8. Jackson, J.: Selected writings of John Hughlings Jackson (Basic Books. New York 1958).
9. Johnstone, E., Crow, T., Frith, C., Husband, J., Krecl, I.: The dementia of dementia praecox. Acta psychiat. scand. 57: 304-324 (1978).
10. Johnstone, E., Crow, T., Frith, C.: Mechanism of the anti-psy- chotic in the treatment of acute schizophrenia. Lancet i: 848-851 (1978).
11. Johnstone, E., Owens, D., Frith, C., Crow, T.: The relative stability of positive and negative features in chronic schizophrenia. Br. J. Psychiat. 150: 60-64 (1986).
12. Meltzer, H.: Dopamine and negative symptoms in schizophrenia: critique of the type I-II hypotheses; in Alport. Controversies in schizophrenia: changes and consistencies, pp. 110-144 (Guildfort Press, New York 1984).
13. Overall, J., Gorham, D.: The brief psychiatric rating scale. Psychol. Rep. 10: 799-812 (1962).
14. Overall, J., Hollister, L., Pichot, P.: Major psychiatric disorders: a four-dimensional model. Archs gen. Psychiat. 16: 146-151 (1967).
15. Phillips, L.: Case history data and prognosis in schizophrenia. J. nerv. ment. Dis. 117: 515-525 (1953).
16. Pinder, R., Brogden, R., Sawyer, P., Speight, T., Spencer, R., Avery, G.S.: Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry. Drugs 12: 1-40 (1976).
17. Rosen, W., Mohs, R., Johns, C., Small, N., Kendler, K., Horvath, T., Davis, K.: Positive and negative symptoms in schizophrenia. Psychiat. Res. 13: 277-284 (1984).
18. Spitzer, R., Endicott, J., Robins, E.: Research diagnostic criteria. New York State Department of Mental Hygiene, New York Psy-chiatric Institute (1978).
19. Thiemann, S., Csernansky, J., Berger, P.: Rating scales in research: the case of negative symptoms. Psychiat. Res. 20: 47-55 (1987).
20. Weinberger, D., Bigelow, L., Kjeinman, J., Wyatt, R.: Cerebral ventricular enlargement in chronic schizophrenia: an association with poor response to treatment. Arehsgen. Psychiat. 37: 11-13 (1980).
21. Van Kammen, D., van Kammen, W., Mann, L., Seppala, T., Linnoila, M.: Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy. Archs gen. Psychiat. 43: 978-983 (1986).
22. van Kammen, D., Rosen, J., Peters, J., Fields, R., van Kammen, W.: Are there state-dependent markers in schizophrenia? Psy- chopharmacol. Bull. 21: 497-502 (1985).